Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Fermi America Q1 2026 Earnings Call - Fermi America Q1 2026 Earnings Call - Leadership Overhaul and 90-Day Tenant Push
Fermi America is executing a forced reset. The board fired the former CEO for cause and installed a new governance structure centered on "Fermi 2.0" to institutionalize operations and attract hypersca...
- Leadership Purge and Governance Reset: Chairman Marius Haas oversaw the termination of former CEO Toby Neugebauer for cause, replacing him with a Co-Presidency structure under the Office of the CEO. The board expanded from five to seven directors, adding veterans from Dell Technologies and power generation to enforce "Fermi 2.0" institutional discipline.
- 90-Day Execution Mandate: Management established a strict 90-day roadmap with five non-negotiable deliverables: securing a binding tenant agreement, maintaining capital discipline, hiring a permanent CEO, delivering power at the site, and exploring strategic data center partnerships.
- Commercial Momentum Accelerates: Following the leadership changes, tenant engagement has intensified significantly. Anna Bofa reported an "exponential" increase in the pipeline, with customers viewing Project Matador as one of the most advanced and customer-ready power campuses in the U.S.
- +7 more takeaways
Ondas Inc Q1 2026 Earnings Call - Revenue Surges Tenfold as Backlog Hits $450M and AI Integration Takes Center Stage
Ondas delivered a breakout first quarter, generating $50.1 million in revenue that represents tenfold year-over-year growth and exceeds the high end of prior guidance. The surge reflects strong demand...
- Q1 2026 revenue reached $50.1 million, a tenfold year-over-year increase and 25% above the high end of prior guidance.
- Product company level EBITDA profitability was achieved two quarters ahead of the internal plan, validating the operating model.
- Backlog expanded to over $450 million following the April acquisitions of World View and Mistral, providing strong visibility into 2026 and beyond.
- +7 more takeaways
Innoviz Technologies Q1 2026 Earnings Call - Defense Traction and Record Shipments Signal Inflection Point
Innoviz delivered a record first quarter with $7.1 million in revenue, driven by a milestone of record unit shipments that were half of its full 2025 volume. While Q1 results fell short of the top end...
- Q1 2026 revenue came in at $7.1 million, reflecting a shift in NRE milestone recognition rather than a lack of demand.
- Record unit shipments in Q1 were approximately half of the total volume shipped in all of 2025, signaling a production ramp at Fabrinet.
- Full-year 2026 revenue guidance remains unchanged at $67 million to $73 million, anticipating roughly 27% year-over-year growth.
- +7 more takeaways
Stantec Q1 2026 Earnings Call - Record Backlog and Margin Expansion Signal Infrastructure Demand Surge
Stantec delivered a strong start to 2026, with net revenue growing 9.1% year-over-year to CAD 1.7 billion, driven by robust organic growth across all regions and a 7.2% contribution from acquisitions....
- Net revenue grew 9.1% year-over-year to CAD 1.7 billion, with 3.6% organic growth and 7.2% driven by acquisitions.
- Adjusted EBITDA margin expanded 70 basis points to 16.9%, reflecting improved utilization and disciplined cost control.
- Contract backlog reached a record CAD 9 billion, representing 13 months of work and a 13.2% year-over-year increase.
- +7 more takeaways
Wolverine World Wide Q1 2026 Earnings Call - Revenue and EPS Beat Driven by Saucony and Merrell Momentum
Wolverine World Wide delivered a strong start to fiscal 2026, with Q1 revenue rising 11% to $458 million and adjusted EPS jumping 32% to $0.25. The beat was led by the Active Group, where Saucony post...
- Q1 revenue reached $458 million, up 11% reported and 7% constant currency, beating the high end of guidance. Adjusted diluted EPS rose 32% to $0.25, exceeding the $0.20-$0.22 outlook.
- Active Group revenue grew 9%, led by Saucony’s record 15% growth and Merrell’s 9% gain. Both brands saw broad-based strength across channels, regions, and categories.
- Work Group revenue was flat, better than the mid-single-digit decline previously expected. Wolverine gained U.S. work boot market share for a second consecutive quarter.
- +7 more takeaways
Prestige Consumer Healthcare Inc. Q4 2026 Earnings Call - Eye Care Supply Chain Disruptions and Strategic Acquisitions Drive Outlong-Term Growth
Prestige Consumer Healthcare Inc. delivered a challenging fourth quarter in fiscal 2026, with revenue declining 4% year-over-year as Clear Eyes faced significant supply chain disruptions and Middle Ea...
- Fiscal 2026 revenue declined approximately 4% organically, driven by Clear Eyes supply constraints and Middle East shipping disruptions.
- Clear Eyes sales fell short of expectations in Q4 due to delayed shipments and extended production shutdowns at the Pillar5 Pharma facility.
- The company acquired Pillar5 Pharma in December 2025 to gain direct control over sterile eye care manufacturing, aiming to improve supply consistency and quality.
- +12 more takeaways
NetSol Technologies Q3 FY2026 Earnings Call - Record Revenue Driven by Mercedes-Benz Renewal and AI Integration
NetSol Technologies delivered a record third quarter with total net revenues of $19.8 million, up 13% year-over-year, driven by a one-time $4.7 million license fee from a Mercedes-Benz contract renewa...
- Record quarterly revenue of $19.8 million, representing 13% year-over-year growth and the highest quarterly top-line in company history.
- Recurring subscription and support revenue grew 11.7% year-over-year to $8.8 million, underscoring the shift toward a predictable, high-margin revenue mix.
- A one-time $4.7 million license fee from a four-year, $50 million Mercedes-Benz contract renewal significantly boosted third-quarter license revenue and provides multi-year visibility into the subscription pipeline.
- +7 more takeaways
Autolus Therapeutics Q1 2026 Earnings Call - First Positive Gross Margin Drives Path to 2028 ALL Profitability
Autolus Therapeutics reported a pivotal shift in its Q1 2026 financial results, achieving its first-ever positive gross margin for AUCATZYL as revenue surged to $26.2 million, nearly tripling year-ove...
- Autolus achieved its first positive gross margin in Q1 2026, a critical inflection point driven by volume growth and manufacturing efficiencies that have halved labor hours per product.
- Revenue nearly tripled year-over-year to $26.2 million, reflecting strong early traction in the U.S. and the initial ramp of the U.K. NHS launch.
- The company is expanding its U.S. commercial footprint to over 73 centers, targeting 80+ by year-end, with growth primarily driven by deeper adoption among existing physicians rather than just new site additions.
- +7 more takeaways
Invivyd {Q1} 2026 Earnings Call - DECLARATION Study Accelerates, PEMGARDA Revenue Grows 22%, and Monoclonal Antibodies Gain Cross-Partisan Support
Invivyd reported a strong Q1 2026, driven by a 22% year-over-year increase in PEMGARDA revenue and accelerated recruitment in its pivotal DECLARATION study for VYD2311. The company's Independent Data ...
- PEMGARDA Revenue Growth: First-quarter revenue from the existing monoclonal antibody PEMGARDA grew 22% year-over-year, defying traditional seasonal lags and indicating sustained demand from vulnerable populations.
- DECLARATION Study Acceleration: Recruitment for the pivotal VYD2311 trial is moving faster than expected, with the Independent Data Monitoring Committee (IDMC) recommending a reduction in post-dose monitoring from two hours to 30 minutes due to strong safety signals.
- Safety vs. Reactogenicity Narrative: Invivyd is positioning VYD2311 as a superior alternative to mRNA vaccines by highlighting its minimal systemic reactogenicity, contrasting it with the high rates of post-vaccine symptoms (headache, fever, chills) observed in recent studies.
- +7 more takeaways
LTC Properties Q1 2026 Earnings Call - SHOP Strategy Accelerates with $600M Acquisition Target on Track
LTC Properties is aggressively pivoting its portfolio toward Senior Housing Operating Partnership (SHOP) assets, a move designed to replace low-growth triple-net leases with higher-yielding, operator-...
- SHOP Portfolio Expansion: LTC expects SHOP assets to account for 40% of annualized NOI by year-end, up from a minimal base, with pro forma portfolio growth accelerating from the low 2% range to 5-7%.
- Acquisition Pace: The company is on track to close $460 million of SHOP acquisitions through Q3 2026, with a $600 million midpoint target for the full year. Nearly $250 million is expected to close in Q2.
- Pipeline Strength: LTC has over $500 million of opportunities under consideration, with 65% of recent deals sourced off-market. The pipeline includes 12 communities across 8 transactions, averaging 10 years in age.
- +7 more takeaways